Sofía Matilla-Almazán

2PUBLICATIONS
12CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 08, 2023
The WNK1-ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib.

Adrián Sánchez-Fdez, Sofía Matilla-Almazán, Juan Carlos Montero

|Jul 27, 2022
ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology.

Elena Arconada-Luque, Jaime Jiménez-Suarez, Raquel Pascual-Serra

Pageof 1

Frequent Collaborators

2 joint publications

Adrián Sánchez-Fdez

2 joint publications

Azucena Esparís-Ogando

1 joint publications

Elena Arconada-Luque

1 joint publications

Francisco J Cimas